Pancreatic Neoplasms: all 3,310 studies
Page 7 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- Para-aortic Lymph Node Metastasis in Resectable Pancreatic CancerRecruitingNCT06065891Not applicable
- Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard TherapyRecruitingNCT06065371Phase 1
- Improving Pancreatic Cancer Care by the Use of Computational Science and TechnologyRecruitingNCT06055010
- Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic CancerRecruitingNCT06051851Phase 2
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionRecruitingNCT06051695Phase 1/2
- Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic CancerRecruitingNCT06050317Phase 2
- Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma PatientsRecruitingNCT06046794Not applicable
- Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized PanelRecruitingNCT06043921
- T Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon CancerRecruitingNCT06043713Phase 1
- A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid TumorsRecruitingNCT06043466Phase 1
- Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other ExaminationsRecruitingNCT06041009
- Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsRecruitingNCT06040541Phase 1
- Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA SequencingRecruitingNCT06036563
- Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic CancerRecruitingNCT06030622Phase 1/2
- Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic CancerRecruitingNCT06026943Not applicable
- Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic CancerRecruitingNCT06018896Phase 2
- Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic CancerRecruitingNCT06017284Phase 3
- Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid TumorsRecruitingNCT06010862Phase 1
- SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)Not yet recruitingNCT06009029Phase 2
- A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.RecruitingNCT06008288Phase 2
- CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid TumorsRecruitingNCT06006390Phase 1/2
- Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the PancreasNot yet recruitingNCT06000553Not applicable
- A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal AdenocarcinomaRecruitingNCT05997147
- A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsRecruitingNCT05989724Phase 1
- Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of ChemotherapyRecruitingNCT05988814Phase 2
- Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)Not yet recruitingNCT05988372Phase 2
- MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRialRecruitingNCT05975593Not applicable
- Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAvailableNCT05974410
- Venous Thromboembolism in Primary Pancreatic Tumour ResectionRecruitingNCT05964621
- Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE StudyRecruitingNCT05961982Not applicable
- Hyperthermia Treatment Added to Chemotherapy Standard of Care for Pancreatic TumorsRecruitingNCT05959395Not applicable
- HTL0039732 in Participants With Advanced Solid TumoursRecruitingNCT05944237Phase 1/2
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsRecruitingNCT05941507Phase 1/2
- LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic CancerRecruitingNCT05939063Not applicable
- A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsRecruitingNCT05932862Phase 1
- Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer PatientsRecruitingNCT05929885Phase 2
- Determining Individualized Cancer Therapy in Pancreatic CancerRecruitingNCT05914987
- Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia.RecruitingNCT05914077Phase 3
- A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic CancerRecruitingNCT05911217Phase 1
- Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cmRecruitingNCT05907824
- Canagliflozin With Gemcitabine in Pancreatic CarcinomaNot yet recruitingNCT05903703Not applicable
- Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic RadiofrequencyRecruitingNCT05871164
- Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic CarcinomaRecruitingNCT05869474Not applicable
- A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic CancerRecruitingNCT05859750Phase 2
- Preoperative Optimisation of Modifiable Risk Factors in Surgery of the PancreasRecruitingNCT05851534Not applicable
- Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer PatientsRecruitingNCT05850130Not applicable
- Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic CancerNot yet recruitingNCT05848154
- In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric CancerRecruitingNCT05842187Not applicable
- Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic CancerRecruitingNCT05841420Phase 2
- A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueRecruitingNCT05837767Not applicable
- Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic CancerRecruitingNCT05832892Phase 1/2
- A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid TumorsRecruitingNCT05830097Phase 1/2
- IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic CancerRecruitingNCT05827796Phase 1/2
- Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic CancerNot yet recruitingNCT05810792Phase 2
- The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic CancerRecruitingNCT05802407Not applicable
- The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic CancerRecruitingNCT05802394Not applicable
- Utidelone Injection Combined With Gemcitabine in First-line Chemotherapy for Unresectable Advanced Pancreatic CancerRecruitingNCT05795920Phase 2
- METabolic PROFILE of Hepatocarcinoma and Pancreatic TumorsRecruitingNCT05794048Not applicable
- DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating MutationsRecruitingNCT05786716Phase 2/3
- SBRT Plus vNKT for Pancreatic CancerRecruitingNCT05783076Phase 2
- Mesothelin/GPC3/GUCY2C-CAR-T Cells Against CancersRecruitingNCT05779917Phase 1
- Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic CancerRecruitingNCT05776524Phase 2
- Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic CancerRecruitingNCT05766748Phase 1/2
- Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized ApproachRecruitingNCT05764720Not applicable
- First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid TumoursRecruitingNCT05759923Phase 1
- HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic CancerRecruitingNCT05751850Phase 3
- Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trialRecruitingNCT05744219Phase 3
- Collection of Circulating Biomarkers in Pancreatic CancerRecruitingNCT05743049
- The PREPAIRD Study: Personalized Surveillance for Early Detection of Pancreatic Cancer in High Risk IndividualsEnrolling by invitationNCT05740111Not applicable
- Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid SamplesRecruitingNCT05737953
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsRecruitingNCT05733000Phase 2
- Radiographic Response to Chemotherapy in Unresected Localized Pancreatic CancerRecruitingNCT05729737
- Volatile Organic Compound Assessment in Pancreatic Ductal AdenocarcinomaRecruitingNCT05727020
- Familial Pancreatic Cancer PROPHilation Program in ItalyRecruitingNCT05724992Not applicable
- EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)RecruitingNCT05723107Phase 1
- Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?RecruitingNCT05720338Phase 3
- FGF19 in Obstructive Cholestasis: "Unveil the Signal"RecruitingNCT05718349
- Radiology Registry on Pancreatic MalignanciesRecruitingNCT05714111
- Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine TumorsRecruitingNCT05687123Phase 1
- Tislelizumab With Anlotinib and Chemotherapy for Second-line Treatment of Pancreatic CancerRecruitingNCT05681390Phase 2
- Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas CancerRecruitingNCT05679674Not applicable
- Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic CancerRecruitingNCT05679583Phase 2
- Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic CancerRecruitingNCT05679050Phase 2
- A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering DrugsRecruitingNCT05663515
- Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety)RecruitingNCT05657743Not applicable
- Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic CancerRecruitingNCT05653453Phase 3
- REVOLUTION Surgery (REVOLUTION Surgery)RecruitingNCT05642819
- Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic HeadNot yet recruitingNCT05637567Phase 2
- ExoLuminate Study for Early Detection of Pancreatic CancerRecruitingNCT05625529
- Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-TRecruitingNCT05620732Not applicable
- A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic CancerRecruitingNCT05616494Phase 2
- Microbiota and Pancreatic Cancer CachexiaRecruitingNCT05606523
- Cross-sectional Follow-up on Digestive and Social Functions of SPNRecruitingNCT05604716
- A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas CancerRecruitingNCT05604560Phase 2
- Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor MicroenvironmentEnrolling by invitationNCT05600933
- EUS-guided Choledochoduodenostomy for Primary Drainage of Malignant Distal Biliary ObstructionRecruitingNCT05595122Not applicable
- Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation TherapyNot yet recruitingNCT05585554Not applicable
- Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer PatientsRecruitingNCT05580887
- Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic CancerRecruitingNCT05580445Phase 1/2
- EUS-FNI for Nonfunctional Pancreatic Neuroendocrine TumorsRecruitingNCT05566093Not applicable